<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03429881</url>
  </required_header>
  <id_info>
    <org_study_id>HCB/2015/0068</org_study_id>
    <nct_id>NCT03429881</nct_id>
  </id_info>
  <brief_title>Microparticle Generation After Laparoscopic Surgical Treatment for Endometrioma.</brief_title>
  <official_title>Microparticle Generation After Laparoscopic Surgical Treatment for Endometrioma: a Pilot, Prospective, Randomized Study Comparing Stripping With CO2 Laser Vaporization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Francisco Carmona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study objective: To evaluate serial generation of microparticles (MPs) after laparoscopic
      stripping or CO2 laser vaporization in surgical treatment of patients with ovarian
      endometrioma (OE).

      Design: A prospective, randomized, blinded, pilot study, including 33 patients. Setting:
      Tertiary university hospital from April 2015 to June 2017. Patients: 33 women with unilateral
      OE undergoing laparoscopic surgery. Intervention: Patients were randomly selected to undergo
      either CO2 laser vaporization (L group) or laparoscopic stripping (S group) of OE.

      Measurements and Main results: Blood samples were collected before surgery, and at 2 hours,
      24 hours, 1 month, and 3 months after surgery. MPs generation curve after ovarian
      endometrioma surgery was performed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 5, 2018</start_date>
  <completion_date type="Actual">February 5, 2018</completion_date>
  <primary_completion_date type="Actual">February 5, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microparticle levels after two laparoscopic treatments of ovarian endometriomas</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Microparticle</condition>
  <condition>Endometriosis</condition>
  <condition>Laparoscopy</condition>
  <arm_group>
    <arm_group_label>Laparoscopic stripping ovarian endometriomas</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Laser CO2 treatment ovarian endometriomas</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stripping versus laser CO2</intervention_name>
    <description>Patients were randomly selected to undergo either CO2 laser vaporization (L group) or laparoscopic stripping (S group) of OE.</description>
    <arm_group_label>Laparoscopic stripping ovarian endometriomas</arm_group_label>
    <arm_group_label>Laser CO2 treatment ovarian endometriomas</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18 and 40 years and unilateral symptomatic OEs â‰¥3 cm.

        Exclusion Criteria:

          -  previous pelvic surgery, history of cancer, suspected malignancy, presurgical
             suspicion or evidence of deep endometriosis, presurgical suspicion or evidence of
             premature ovarian failure, and the use of estrogen suppressive drugs, including oral
             contraceptives, GnRH-agonists, progestins, or danazol in the preceding 3 months. We
             excluded patients with suspicion of deep endometriosis according to an extensive
             preoperative work-up (including magnetic resonance imaging when necessary) routinely
             performed in such patients.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2018</study_first_submitted>
  <study_first_submitted_qc>February 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2018</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Francisco Carmona</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Publication in an indexed journal</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

